Dual-targeting triplebody 33-3-19 mediates selective lysis of biphenotypic CD19+ CD33+ leukemia cells

Title
Dual-targeting triplebody 33-3-19 mediates selective lysis of biphenotypic CD19+ CD33+ leukemia cells
Authors
Keywords
leukemia, mixed phenotype acute leukemia (MPAL), immunotherapy, dual-targeting triplebody, selectivity
Journal
Oncotarget
Volume 7, Issue 16, Pages -
Publisher
Impact Journals, LLC
Online
2016-03-10
DOI
10.18632/oncotarget.8022

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation